Literature DB >> 25257883

A case report of intracranial infection caused by Shewanella putrefaciens.

Mengxi Duan1, Dali Wang, Jing Wang, Xiaoguang Xiao, Lixia Han, Fenghua Zhang.   

Abstract

Shewanella putrefaciens is as yet reputed to be a rare conditional pathogen. In recent years, some clinical infections caused by Shewanella putrefaciens came into view, and it was possible for the bacteria to be isolated from blood, pus, urine, sputum, and wound secretions, etc. A transferred patient who suffered from intracranial infection after operation of cerebral hemorrhage was admitted in the First Affiliated Hospital of Dalian Medical University. To ascertain the cause, we assessed her blood, cerebrospinal fluid and sputum specimen, and succeeded in isolating one strain of bacteria from her cerebrospinal fluid. To circumvent the potential problem, further detection by Dade Behring Microscan WalkAway 96SI system and drug sensitivity identification plate was performed. Corresponding results indicated that the bacteria were certain pseudomonas with high drug resistance, only sensitive to ticarcillin/clavulanic acid and Imipenem. Eventually by 16S rDNA amplification assay, a new technique to identify pathogens genome, Shewanella putrefaciens infection was confirmed with 99 % coincidence rate. This is the first time in our hospital that Shewanella putrefaciens in the cerebrospinal fluid specimen was detected. When considering the increase of opportunistic infection, it is noteworthy to pay more attention to such situations in clinical diagnoses.

Entities:  

Mesh:

Year:  2014        PMID: 25257883     DOI: 10.1007/s10072-014-1956-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  6 in total

1.  16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates.

Authors:  M Drancourt; C Bollet; A Carlioz; R Martelin; J P Gayral; D Raoult
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

Review 2.  Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics.

Authors:  H M Holt; B Gahrn-Hansen; B Bruun
Journal:  Clin Microbiol Infect       Date:  2005-05       Impact factor: 8.067

3.  [Soft tissue infection associated with bacteremia caused by Shewanella putrefaciens].

Authors:  N Rouzic; G Héry-Arnaud; S Jaffuel; B Garo; C Payan; M Garré
Journal:  Pathol Biol (Paris)       Date:  2011-05-26

Review 4.  First case of human spondylodiscitis due to Shewanella algae.

Authors:  Mélanie Gressier; Didier Mbayo; Hervé Deramond; Franck Grados; François Eb; Brigitte Canarelli
Journal:  Int J Infect Dis       Date:  2010-02-18       Impact factor: 3.623

5.  Ventilator-associated pneumonia due to Shewanella putrefaciens.

Authors:  Calvin Tucker; Genelyn Baroso; Paul Tan
Journal:  Am J Health Syst Pharm       Date:  2010-06-15       Impact factor: 2.637

6.  Necrotizing fasciitis caused by Shewanella putrefaciens in a uremic patient.

Authors:  Tsung-Hung Tsai; Hong-Yi You
Journal:  J Microbiol Immunol Infect       Date:  2006-12       Impact factor: 4.399

  6 in total
  4 in total

Review 1.  Current trends of human infections and antibiotic resistance of the genus Shewanella.

Authors:  K Yousfi; S Bekal; V Usongo; A Touati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-15       Impact factor: 3.267

2.  Case Report: Disseminated Shewanella algae Infection with Meningoencephalitis in a Traveler Secondary to Marine Injury in Madagascar.

Authors:  Caroline Brulliard; Nicolas Traversier; Jérôme Allyn; Christopher Schaeffer; Bruno Bouchet; Nicolas Allou
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

3.  Shewanella spp. infections in Gran Canaria, Spain: retrospective analysis of 31 cases and a literature review.

Authors:  Alberto J Martín-Rodríguez; Oriol Martín-Pujol; Fernando Artiles-Campelo; Margarita Bolaños-Rivero; Ute Römling
Journal:  JMM Case Rep       Date:  2017-12-07

Review 4.  Shewanella infection in humans: Epidemiology, clinical features and pathogenicity.

Authors:  Keyi Yu; Zhenzhou Huang; Yue Xiao; Duochun Wang
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.